References
- Afuwape, A.O., Kiriakidis, S., and Paleolog, E.M., 2002. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Histology and histopathology, 17 (3), 961–972.
- Alarcon, G.S., et al., 1982. Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis and rheumatism, 25 (5), 502–507.
- Aletaha, D., et al., 2010. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis and rheumatism, 62 (9), 2569–2581.
- Al-Rugeebah, A., Alanazi, M., and Parine, N.R., 2019. MEG3: an oncogenic long non-coding RNA in different cancers. Pathology oncology research: pathology & oncology research, 25 (3), 859–874.
- Arend, W.P., and Firestein, G.S., 2012. Pre-rheumatoid arthritis: predisposition and transition to clinical synovitis. Nature reviews. Rheumatology, 8 (10), 573–586.
- Benetatos, L., Vartholomatos, G., and Hatzimichael, E., 2011. MEG3 imprinted gene contribution in tumorigenesis. International journal of cancer, 129 (4), 773–779.
- Bottini, N., and Firestein, G.S., 2013. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nature reviews. rheumatology, 9 (1), 24–33.
- Charan, J., and Biswas, T., 2013. How to calculate sample size for different study designs in medical research? Indian journal of psychological medicine, 35 (2), 121–126.
- Chimenti, M., et al., 2015. The interplay between inflammation and metabolism in rheumatoid arthritis. Cell death & disease, 6 (9), e1887
- da Rocha, S.T., et al., 2008. Genomic imprinting at the mammalian Dlk1-Dio3 domain. Trends genet, 24 (6), 306–316.
- Dechamethakun, S., and Muramatsu, M., 2017. Long noncoding RNA variations in cardiometabolic diseases. Journal of human genetics, 62 (1), 97–104.
- Ghosh, S., and Castellanos-Rubio, A., 2019. Disease-associated SNPs in inflammation-related lncRNAs. Frontiers in immunology, 10, 420.
- Guo, Q., et al., 2018. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone research, 6 (1), 15.
- He, C., et al., 2017. Long Noncoding RNA MEG3 Negatively Regulates Proliferation and Angiogenesis in Vascular Endothelial Cells. DNA cell biol, 36 (6), 475–481.
- Hu, F., et al., 2014. Hypoxia and hypoxia-inducible factor-1α provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Annals of the rheumatic diseases, 73 (5), 928–936.
- Hu, X.Q., et al., 2017. Chronic hypoxia upregulates DNA methyltransferase and represses large conductance Ca2+-activated K + channel function in ovine uterine arteries. Biology of reproduction, 96 (2), 424–434.
- Ivan, M., et al., 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (New York, N.Y.), 292 (5516), 464–468.
- Kiani, A.K., et al., 2015. Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients. Immunogenetics, 67 (5–6), 277–282.
- Knijff-Dutmer, E., et al., 2002. Rheumatoid factor measured by fluoroimmunoassay: a responsive measure of rheumatoid arthritis disease activity that is associated with joint damage. Annals of the rheumatic diseases, 61 (7), 603–607.
- Li, H., and Wan, A., 2013. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediators of inflammation, 2013, 953462.
- Liang, J., Chen, W., and Lin, J., 2019. LncRNA: an all-rounder in rheumatoid arthritis. Journal of translational internal medicine, 7 (1), 3–9.
- Liu, Y.R., et al., 2019. Long noncoding RNA MEG3 regulates rheumatoid arthritis by targeting NLRC5. Journal of cellular physiology, 234 (8), 14270–14284.
- Lu, X., and Qian, J., 2019. Downregulated MEG3 participates in rheumatoid arthritis via promoting proliferation of fibroblast-like synoviocytes. Experimental and therapeutic medicine, 17 (3), 1637–1642.
- Luo, G., et al., 2015. Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology, 37 (6), 2209–2220.
- Mann, D.A., 2014. Epigenetics in liver disease. Hepatology (Baltimore, Md.), 60 (4), 1418–1425.
- Motterle, A., Sanchez-Parra, C., and Regazzi, R., 2016. Role of long non-coding RNAs in the determination of beta-cell identity. Diabetes, obesity and metabolism, 18 (Suppl. 1), 41–50.
- Nourshargh, S., and Alon, R., 2014. Leukocyte migration into inflamed tissues. Immunity, 41 (5), 694–707.
- Peschansky, V.J., and Wahlestedt, C., 2014. Non-coding RNAs as direct and indirect modulators of epigenetic regulation. Epigenetics, 9 (1), 3–12.
- Qin, G., et al., 2006. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF. Proceedings of the National Academy of Sciences of the United States of America, 103 (29), 11015–11020.
- Quiñonez-Flores, C.M., González-Chávez, S.A., and Pacheco-Tena, C., 2016. Hypoxia and its implications in rheumatoid arthritis. Journal of biomedical science, 23 (1), 62.
- Ruhrmann, S., et al., 2015. Genomic imprinting: a missing piece of the multiple sclerosis puzzle? The international journal of biochemistry & cell biology, 67, 49–57.
- Rutenberg-Schoenberg, M., Sexton, A.N., and Simon, M.D., 2016. The properties of long noncoding RNAs that regulate chromatin. Annual review of genomics and human genetics, 17, 69–94.
- Smolen, J.S., et al., 2018. Rheumatoid arthritis. Nature reviews. disease primers, 4, 18001.
- Su, W., et al., 2015. The long noncoding RNA MEG3 is downregulated and inversely associated with VEGF levels in osteoarthritis. BioMed research international, 2015, 356893.
- Sulaiman, F.N., et al., 2019. Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients. Medicine, 98 (12), e14945.
- van der Heijde, D.M., et al., 1990. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Annals of the rheumatic diseases, 49 (11), 916–920.
- Wallace, C., et al., 2010. The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes. Nature Genetics, 42 (1), 68–71.
- Wang, G.L., et al., 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proceedings of the National Academy of Sciences of the United States of America, 92 (12), 5510–5514.
- Weinmann, M., et al., 2004a. Cyclic exposure to hypoxia and reoxygenation selects for tumor cells with defects in mitochondrial apoptotic pathways. FASEB journal: official publication of the federation of American societies for experimental biology, 18 (15), 1906–1908.
- Weinmann, M., et al., 2004b. Molecular ordering of hypoxia-induced apoptosis: critical involvement of the mitochondrial death pathway in a FADD/caspase-8 independent manner. Oncogene, 23 (21), 3757–3769.
- Zhang, X., et al., 2019. LncRNA MEG3 inhibits cell proliferation and induces apoptosis in laryngeal cancer via miR-23a/APAF-1 axis. Journal of cellular and molecular medicine, 23 (10), 6708–6719.
- Zhao, J., et al., 2005. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. The journal of clinical endocrinology and metabolism, 90 (4), 2179–2186.